Andreas Unterberg

Author PubWeight™ 100.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009 7.73
2 Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012 6.71
3 Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 2014 5.79
4 Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015 5.71
5 Dissecting the genomic complexity underlying medulloblastoma. Nature 2012 4.77
6 Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008 3.22
7 European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014 2.71
8 Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007 2.56
9 Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 2013 2.42
10 Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010 2.07
11 Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006 1.91
12 ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 2014 1.66
13 Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res 2009 1.61
14 Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res 2011 1.61
15 Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours. Cancer Treat Rev 2006 1.58
16 European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013 1.50
17 Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 2013 1.49
18 Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 2004 1.48
19 Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathol 2014 1.42
20 Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 2006 1.28
21 IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol 2015 1.13
22 Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. BMC Cancer 2010 1.06
23 Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 2003 1.04
24 Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Mol Cancer Res 2009 1.03
25 Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience. Pain 2006 1.03
26 AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. Acta Neuropathol 2013 1.03
27 Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer 2010 1.02
28 Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien) 2009 1.02
29 DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke 2011 1.01
30 Stroke-related Early Tracheostomy versus Prolonged Orotracheal Intubation in Neurocritical Care Trial (SETPOINT): a randomized pilot trial. Stroke 2012 1.01
31 Surgical treatment of intracerebral haemorrhage. Curr Opin Crit Care 2007 0.98
32 No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas. J Neurooncol 2012 0.97
33 The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int 2012 0.97
34 Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 2015 0.97
35 Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation. J Clin Invest 2010 0.95
36 Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial. BMC Cancer 2010 0.94
37 Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care 2007 0.94
38 Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers 2011 0.91
39 Intensive care management of acute stroke: surgical treatment. Int J Stroke 2010 0.90
40 Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial. BMC Cancer 2010 0.89
41 Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Methods 2007 0.89
42 Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation. J Neurosurg 2009 0.89
43 Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. Am J Pathol 2011 0.88
44 Current recommendations for neurotrauma. Curr Opin Crit Care 2000 0.87
45 Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas. Int J Cancer 2012 0.86
46 Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain. Acta Neuropathol 2015 0.86
47 One life ends, another begins: Management of a brain-dead pregnant mother-A systematic review-. BMC Med 2010 0.86
48 Expression and regulation of AC133 and CD133 in glioblastoma. Glia 2011 0.85
49 Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. J Pathol 2014 0.85
50 Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma. J Neurooncol 2014 0.84
51 Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status. Anticancer Res 2007 0.83
52 Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib. Anticancer Res 2009 0.82
53 MRI of the perihemorrhagic zone in a rat ICH model: effect of hematoma evacuation. Neurocrit Care 2008 0.82
54 Antiglioma activity of 2,2':6',2"-terpyridineplatinum(II) complexes in a rat model--effects on cellular redox metabolism. Free Radic Biol Med 2005 0.82
55 Evaluation of a novel brain tissue oxygenation probe in an experimental swine model. Neurosurgery 2010 0.81
56 Potential canonical wnt pathway activation in high-grade astrocytomas. ScientificWorldJournal 2012 0.80
57 Characteristics of thoracolumbar intramedullary subependymomas. J Neurosurg Spine 2009 0.80
58 Using video-oculography for galvanic evoked vestibulo-ocular monitoring in comatose patients. J Neurosci Methods 2005 0.80
59 New European directive on clinical trials: implications for traumatic head injury research. Intensive Care Med 2004 0.80
60 Decompressive surgery for severe brain edema. J Intensive Care Med 2009 0.80
61 Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib. Anticancer Res 2009 0.80
62 Cortical spreading depression dynamics can be studied using intrinsic optical signal imaging in gyrencephalic animal cortex. Acta Neurochir Suppl 2013 0.80
63 New European Directive on clinical trials. Lancet 2003 0.79
64 Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. Cancer Sci 2010 0.79
65 Cerebral glucose and spreading depolarization in patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2013 0.78
66 Decompressive craniectomy in patients with aneurysmal subarachnoid hemorrhage: a single-center matched-pair analysis. Cerebrovasc Dis 2014 0.78
67 Quantitative sensory testing in patients with chronic unilateral radicular neuropathic pain and active spinal cord stimulation. Neuromodulation 2006 0.78
68 Low-frequency sampling for PRx calculation does not reduce prognostication and produces similar CPPopt in intracerebral haemorrhage patients. Acta Neurochir (Wien) 2011 0.77
69 Influence of isoflurane on neuronal death and outcome in a rat model of traumatic brain injury. Acta Neurochir Suppl 2012 0.77
70 The Hemodynamic Response of Spreading Depolarization Observed by Near Infrared Spectroscopy After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 2015 0.76
71 SU11657 enhances radiosensitivity of human meningioma cells. Int J Radiat Oncol Biol Phys 2008 0.76
72 Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage. Neurocrit Care 2010 0.75
73 Pressure reactivity index correlates with metabolic dysfunction in a porcine model of intracerebral hemorrhage. Acta Neurochir Suppl 2012 0.75
74 Hemicraniectomy for middle-cerebral-artery stroke. Author reply. N Engl J Med 2014 0.75
75 Perihemorrhagic ischemia occurs in a volume-dependent manner as assessed by multimodal cerebral monitoring in a porcine model of intracerebral hemorrhage. Neurocrit Care 2015 0.75
76 The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage. Br J Neurosurg 2010 0.75
77 Selective neck occlusion of a large complex aneurysm of the middle cerebral artery trifurcation with the UltraSoft coil. AJNR Am J Neuroradiol 2002 0.75
78 Evaluation of a New Brain Tissue Probe for Cerebral Blood Flow Monitoring in an Experimental Pig Model. Neurosurgery 2016 0.75
79 Evidence of spreading depolarizations in a porcine cortical intracerebral hemorrhage model. Acta Neurochir Suppl 2012 0.75
80 Trauma care in Germany: a European perspective. Clin Neurosurg 2007 0.75
81 Comparative study of application accuracy of two frameless neuronavigation systems: experimental error assessment quantifying registration methods and clinically influencing factors. Neurosurg Rev 2011 0.75
82 Pulmonary air embolism in severe head injury. Resuscitation 2003 0.75